Tag: Quality Systems

Addressing Tech Transfer Readiness Gaps during Comparability Assessment: A Structured Investigative Approach Tech transfer readiness gaps can significantly impede the comparability assessment process, leading to deviations that are costly and…

Understanding the Implications of Excipient Variability During Early Development In pharmaceutical manufacturing, excipients play a critical role in ensuring the efficacy and stability of drug formulations. However, variability in excipients…

Addressing Underestimated Formulation Robustness during Scale-Up: Key Steps for Effective Tech Transfer In the pharmaceutical industry, the inadequacy of formulation robustness can significantly impact product quality during scale-up processes. Such…

Addressing Method Development Instability During Pilot Scale: Implications for Regulatory Scrutiny In the context of pharmaceutical development, method instability during pilot scale processes often results in significant challenges. These challenges…

Addressing Method Development Instability During the Early Development Lifecycle In the pharmaceutical landscape, method development instability can pose significant challenges, particularly during the early phases of product development. Instabilities can…

Improving Data Package for Regulatory Filing When Process Knowledge is Lacking During Pilot Scale In pharmaceutical development, capturing process knowledge during pilot scale manufacturing is critical for ensuring product quality…

Addressing Readiness Gaps for a Seamless Transfer to Manufacturing When transitioning from research and development to manufacturing, organizations often encounter significant readiness gaps that may jeopardize compliance with Good Manufacturing…

Understanding Method Development Instability in Early Stages and Its Regulatory Implications Method development is a critical phase in pharmaceutical research and development, where the stability of methods significantly affects regulatory…

Addressing Poor Justification of Design Space During Manufacturing Transfers to Mitigate GMP Risks In the pharmaceutical industry, ensuring that the design space for a product is adequately justified during the…

Understanding Method Development Instability During Comparability Assessment: CAPA Strategies for Development Lifecycle In the highly regulated pharmaceutical industry, method development instability during a comparability assessment can lead to significant challenges…

Assessing the Impact of Excipient Variability During Comparability: An Investigation Framework In the pharmaceutical industry, the variability of excipients can present significant challenges, especially during comparability assessments. These assessments are…

“`html Addressing Uncaptured Process Knowledge During Pilot Scale for Effective Tech Transfer In the pharmaceutical manufacturing environment, capturing comprehensive process knowledge during the pilot scale can often be overlooked, leading…